The Code for Transparency in Clinical Research (herinafter the Code) is the firm commitment of the clinical trial centres (trial organisers, helath professionals and patients), which participate in the "Development and Internationalisation of the Thematic Network for Clinical Research" (EFOP-3.6.2-16-2017-00009), to employ common principles for the transparency of clinical trials.
There is a strong demand from patients, sponsors and professional stakeholders for clinical trial centres to be fully accountable and transparent. For these reasons, the clinical trial centres are committed to appropriate transparency and, as far as possible, uniformity. By standardising the principles of transparency of the clinical trial centres, the activities of each centre can be assessed clearly. This is making it easier to establish a common ground for action with professional partners. At the same time, there is an increased demand from patients to obtain more information on clinical trials, including the process and the background of the trials. The information available to professional partners facilitates contact, contracting ad administrative processes.
This Transparency Code was adopted by the clinical trial centres and entered into force on 05 May 2019.
The aim of the clinical trial centres is to increase trust on behalf of the clients, professional participants, patients and their relatives. The Code also aims to ensure that each clinical trial centres presents professional information on clinical research in a uniform way, and that the operation, benefits and professional background of each clinical trial centres are easily undesatndable. This information is professionally relevant for investigators and sponsors and informative for the ly public.